Stent mediated Gene and Drug delivery for Cardiovascular Disease and Cancer: a brief insight

ConclusionFurther delve into improvisation of next generation DES to an extent has helped in overcoming the issue of restenosis. However, current stent formulations fall short of anticipated clinically meaningful outcomes and there is an explicit need for more randomized trials to further evaluate stent platforms in favour of enhanced safety and clinical value. GES may hold promise in contributing new ideas for stent based prevention of in‐stent restenosis through genetic interventions by capitalizing wide variety of molecular targets. Therefore, the heart of the matter directs us to foresee in finding an ideal stent therapeutic platform that would tackle all gaps in the existing technology.
Source: The Journal of Gene Medicine - Category: Genetics & Stem Cells Authors: Tags: REVIEW ARTICLE Source Type: research